Insulin in patients with acute myocardial infarction and diabetes - friend or foe? A report from the DIGAMI 2 study

被引：0
|
作者：
Mellbin, L. G. [1 ]
Malmberg, K. [1 ]
Norhammar, A. [1 ]
Wedel, H. [2 ]
Ryden, L. [1 ]
机构：
[1] Karolinska Inst, Dept Cardiol, Stockholm, Sweden
[2] Nord Sch Publ Hlth, Gothenburg, Sweden
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
37
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Insulin in patients with acute myocardial infarction and diabetes, friend or foe? A report from the Digami 2 study
    Mellbin, L.
    Malmberg, K.
    Norhammar, A.
    Wedel, H.
    Ryden, L.
    EUROPEAN HEART JOURNAL, 2010, 31 : 343 - 344
  • [2] Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus -: Results from the DIGAMI study
    Almbrand, B
    Johannesson, M
    Sjöstrand, B
    Malmberg, K
    Rydén, L
    EUROPEAN HEART JOURNAL, 2000, 21 (09) : 733 - 739
  • [3] Complement Activation and Prognosis in Patients With Type 2 Diabetes and Myocardial Infarction A report from the DIGAMI 2 trial
    Mellbin, Linda G.
    Bjerre, Mette
    Thiel, Steffen
    Hansen, Troels K.
    DIABETES CARE, 2012, 35 (04) : 911 - 917
  • [4] DIGAMI (Diabetes mellitus, insulin glucose infusion in acute myocardial infarction): Theory and practice
    Davies, MJ
    Lawrence, IG
    DIABETES OBESITY & METABOLISM, 2002, 4 (05): : 289 - 295
  • [5] Complement activation and prognosis in patients with myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial
    Mellbin, L. G.
    Ryden, L.
    Bjerre, M.
    Hansen, T. K.
    DIABETOLOGIA, 2011, 54 : S58 - S58
  • [6] Low LDL cholesterol in acute myocardial infarction patients: friend or foe?
    Moura Ferreira, J.
    Moreira, N.
    Soares, F.
    Ferreira, A. R.
    Mendes, S.
    Leite, L.
    Monteiro, S.
    Goncalves, F.
    Monteiro, P.
    Pego, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 494 - 495
  • [7] Copeptin, IGFBP-1, and Cardiovascular Prognosis in Patients With Type 2 Diabetes and Acute Myocardial Infarction A report from the DIGAMI 2 trial
    Mellbin, Linda G.
    Ryden, Lars
    Brismar, Kerstin
    Morgenthaler, Nils G.
    Ohrvik, John
    Catrina, Sergiu B.
    DIABETES CARE, 2010, 33 (07) : 1604 - 1606
  • [8] Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
    L. G. Mellbin
    K. Malmberg
    A. Norhammar
    H. Wedel
    L. Rydén
    Diabetologia, 2011, 54 : 1308 - 1317
  • [9] The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial
    Mellbin, Linda G.
    Malmberg, Klas
    Ryden, Lars
    Wedel, Hans
    Vestberg, Daniel
    Lind, Marcus
    EUROPEAN HEART JOURNAL, 2013, 34 (05) : 374 - 379
  • [10] Insulin treatment post myocardial infarction:: The Digami study
    Malmberg, K
    Norhammar, A
    Rydén, L
    DIABETES AND CARDIOVASCULAR DISEASE: ETIOLOGY, TREATMENT, AND OUTCOMES, 2001, 498 : 279 - 284
12345